{
    "Trade/Device Name(s)": [
        "Rightest Blood Glucose Monitoring System, Model GM550",
        "Rightest GS550 Blood Glucose Test Strips",
        "Rightest Control Solutions"
    ],
    "Submitter Information": "Bionime Corporation",
    "510(k) Number": "K092052",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042678",
        "K053635",
        "K062567"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "June 04, 2010",
    "Summary Letter Received Date": "June 07, 2010",
    "Submission Date": "June 01, 2010",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Rightest Blood Glucose Meter GM550"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical sensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Control Solution",
        "Meter",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for the Rightest Blood Glucose Monitoring System, Model GM550 for quantitative measurement of glucose in capillary whole blood using electrochemical detection.",
    "Indications for Use Summary": "For quantitative measurement of glucose in capillary whole blood from fingertip, palm, and forearm by healthcare professionals or diabetics at home to aid diabetes management; not for neonatal blood or diabetes diagnosis/screening.",
    "fda_folder": "Clinical Chemistry"
}